Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning : a randomised controlled trial
| dc.contributor.author | Bateman, D Nicholas | |
| dc.contributor.author | Dear, James W | |
| dc.contributor.author | Thanacoody, H K Ruben | |
| dc.contributor.author | Thomas, Simon H L | |
| dc.contributor.author | Eddleston, Michael | |
| dc.contributor.author | Sandilands, Euan A | |
| dc.contributor.author | Coyle, Judy | |
| dc.contributor.author | Cooper, Jamie G | |
| dc.contributor.author | Rodriguez, Aryelly | |
| dc.contributor.author | Butcher, Isabella | |
| dc.contributor.author | Lewis, Steff C | |
| dc.contributor.author | Vliegenthart, A D Bastiaan | |
| dc.contributor.author | Veiraiah, Aravindan | |
| dc.contributor.author | Webb, David J | |
| dc.contributor.author | Gray, Alasdair | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2014-12-23T10:41:00Z | |
| dc.date.available | 2014-12-23T10:41:00Z | |
| dc.date.issued | 2014-02-22 | |
| dc.description | Acknowledgments We thank our colleagues in the treating hospitals who assisted with recruitment and patients’ management, the Data Monitoring Committee (R E Ferner, J E Gray, and K Simpson), and the programmers in the Edinburgh Clinical Trials Unit. The trial was funded by Chief Scientist Office, Scotland (award CZB/4/722). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 8 | |
| dc.format.extent | 415339 | |
| dc.identifier | 45139085 | |
| dc.identifier | 2be97672-b077-48ca-bad4-2515a48c71fe | |
| dc.identifier | 24290406 | |
| dc.identifier | 84894030764 | |
| dc.identifier.citation | Bateman, D N, Dear, J W, Thanacoody, H K R, Thomas, S H L, Eddleston, M, Sandilands, E A, Coyle, J, Cooper, J G, Rodriguez, A, Butcher, I, Lewis, S C, Vliegenthart, A D B, Veiraiah, A, Webb, D J & Gray, A 2014, 'Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning : a randomised controlled trial', The Lancet, vol. 383, no. 9918, pp. 697-704. https://doi.org/10.1016/S0140-6736(13)62062-0 | en |
| dc.identifier.doi | 10.1016/S0140-6736(13)62062-0 | |
| dc.identifier.issn | 0140-6736 | |
| dc.identifier.other | ORCID: /0000-0003-3812-7026/work/188766610 | |
| dc.identifier.uri | http://hdl.handle.net/2164/4126 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | The Lancet | en |
| dc.subject | Acetaminophen | en |
| dc.subject | Acetylcysteine | en |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Alanine Transaminase | en |
| dc.subject | Antiemetics | en |
| dc.subject | Double-Blind Method | en |
| dc.subject | Drug Administration Schedule | en |
| dc.subject | Drug Therapy, Combination | en |
| dc.subject | Female | en |
| dc.subject | Great Britain | en |
| dc.subject | Humans | en |
| dc.subject | Infusions, Intravenous | en |
| dc.subject | Liver Failure, Acute | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Nausea | en |
| dc.subject | Ondansetron | en |
| dc.subject | Poisoning | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | Vomiting | en |
| dc.subject | R Medicine (General) | en |
| dc.subject.lcc | R1 | en |
| dc.title | Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning : a randomised controlled trial | en |
| dc.type | Journal article | en |
